biomarker

dry eye dry skin
Biotech

Oculis sees promise in dry eye disease subgroup, plans phase 3

Oculis is advancing its precision medicine approach to dry eye disease, outlining plans to finalize a phase 3 study after seeing signs of efficacy.
Nick Paul Taylor Jun 10, 2024 7:20am
brain machine learning AI digital neuroscience

Alto's 2nd precision psychiatry med improves depression symptoms

Dec 4, 2023 5:00pm
target reach ladder climb meet win beat competition

Alnylam's RNAi approach to Alzheimer's reaches biomarker target

Jul 17, 2023 2:21am
visual of neurons under Parkinsons disease

New test detects Parkinson's biomarker before movement symptoms

Apr 18, 2023 6:00am
Handshake

Koneksa links with SSI to advance digital biomarker services

Mar 9, 2023 7:05am
MA

Crown Bioscience, JSR team to acquire IndivuServ unit

Jan 31, 2023 3:10pm